Prohibitin binds to C3 and enhances complement activation

Molecular Immunology

Volumn 44, Issue 8, 2007, Pages 1897-1902

  Mishra, Suresh ^a   Moulik, Saby ^a   Murphy, Liam J ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Complement; Innate immunity; Prohibitin; Proteomic

Indexed keywords

COMPLEMENT COMPONENT C3; PROHIBITIN; PROTEIN; REPRESSOR PROTEIN;

ANIMAL CELL; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT DEFICIENCY; CONTROLLED STUDY; CROSS LINKING; DISSOCIATION CONSTANT; ERYTHROCYTE; IMMUNOPRECIPITATION; INNATE IMMUNITY; LYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEOMICS; SERUM; SHEEP; ANIMAL; CHEMISTRY; HUMAN; IMMUNOLOGY;

OVIS ARIES;

ANIMALS; COMPLEMENT ACTIVATION; COMPLEMENT C3; ERYTHROCYTES; HUMANS; IMMUNITY, NATURAL; PROTEIN BINDING; REPRESSOR PROTEINS; SHEEP;

EID: 34848914211     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2006.09.025     Document Type: Article

References (18)

1. Artal-Sanz M., Tsang W.Y., Willems E.M., Grivell L.A., Lemire B.D., van der Spek H., Nijtmans L.G., and Sanz M.A. The mitochondrial prohibitin complex is essential for embryonic viability and germline function in Caenorhabditis elegans. J. Biol. Chem. 278 (2003) 32091-32099
2. Brasaemle D.L., Dolios G., Shapiro L., and Wang R. Proteomic analysis of proteins associated with lipid droplets of basal and lipolytically stimulated 3T3-L1 adipocytes. J. Biol. Chem. 279 (2004) 46835-46842
3. Engstrom G., Hedblad B., Eriksson K.F., Janzon L., and Lindgarde F. Complement C3 is a risk factor for the development of diabetes: a population-based cohort study. Diabetes 54 (2005) 570-575
4. Fujita T., Endo Y., and Nonaka M. Primitive complement system-recognition and activation. Mol. Immunol. 41 (2004) 103-111
5. Gabrielsson B.G., Johansson J.M., Lonn M., Jernas M., Olbers T., Peltonen M., Larsson I., Lonn L., Sjostrom L., Carlsson B., and Carlsson L.M. High expression of complement components in omental adipose tissue in obese men. Obes. Res. 11 (2003) 699-708
6. Hoyt M.A., Knight D.M., Das A., Miller H.I., and Echols H. Control of phage lambda development by stability and synthesis of CII protein: role of viral cIII and host hflA, himA and himD genes. Cell 31 (1982) 565-573
7. Hornick R.B., Greisman S.E., Woodward T.E., DuPont H.L., Dawkins A.T., and Snyder M.J. Typhoid fever: pathogenesis and immunologic control. N. Engl. J. Med. 283 (1970) 686-691
8. Janssen B.J., Huizinga E.G., Raaijmakers H.C., Roos A., Daha M.R., Nilsson-Ekdahl K., Nilsson B., and Gros P. Structures of complement component C3 provide insights into the function and evolution of immunity. Nature 437 (2005) 505-511
9. Kim K.B., Lee J.W., Lee C.S., Kim B.W., Choo H.J., Jung S.Y., Chi S.Y., Yoon Y.S., Yoon Y.S., and Ko Y.G. Oxidation-reduction respiratory chains and ATP synthase complex are localized in detergent-resistant lipid rafts. Proteomics 6 (2006) 2444-2453
10. Kolonin M.G., Saha P.K., Chan L., Pasqualini R., and Arap W. Reversal of obesity by targeted ablation of adipose tissue. Nat. Med. 10 (2004) 625-632
11. McClung J.K., Jupe E.R., Liu X.T., and Dell'Orco R.T. Prohibitin: potential role in senescence, development and tumor suppression. Exp. Gerontol. 30 (1995) 99-124
12. Mengwasser J., Piau A., Schlag P., and Sleeman J.P. Differential immunization identifies PHB1/PHB2 as blood-borne tumor antigens. Oncogene 23 (2004) 7430-7435
13. Muscari A., Sbano D., Bastagli L., Poggiopollini G., Tomassetti V., Forti P., Boni P., Ravaglia G., Zoli M., and Puddu P. Effects of weight loss and risk factor treatment in subjects with elevated serum C3, an inflammatory predictor of myocardial infarction. Int. J. Cardiol. 100 (2005) 217-223
14. Nadimpalli R., Yalpani N., Johal G.S., and Simmons C.R. Prohibitins, stomatins and plant disease response genes compose a superfamily that controls cell proliferation, ion channels regulation and death. J. Biol. Chem. 275 (2000) 29579-29586
15. Sharma A., and Qadri A. Vi polysaccharide of Salmonella typhi targets the prohibitin family of molecules in intestinal epithelial cells and suppresses early inflammatory responses. Proc. Natl. Acad. Sci. USA 101 (2004) 17492-17497
16. Terashima M., Kim K.M., Adachi T., Nielsen P.J., Reth M., Kohler G., and Lamers M.C. The IgM antigen receptor of B lymphocytes is associated with prohibitin and a prohibitin-related protein. EMBO J. 13 (1994) 3782-3792
17. Vessal M., Mishra S., Moulik S., and Murphy L.J. Prohibitin attenuates insulin-stimulated glucose and fatty acid oxidation in adipose tissue by inhibition of pyruvate carboxylase. FEBS J. 273 (2006) 568-576
18. Wang S., Nath N., Adlam M., and Chellappan S. Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function. Oncogene 18 (1999) 3501-3510